Professor Oskar Hansson is a senior consultant neurologist at Skåne University Hospital and full professor of neurology at Lund University, Sweden. He leads the Swedish BioFINDER studies, focusing on early diagnosis of Alzheimer's and Parkinson’s diseases through biomarker development. Co-director of Lund University's neuroscience research area, he also oversees clinical research at the Memory Clinic. Lund University (2017-present): Full Professor of Neurology Skåne University Hospital (2012-present): Senior Consultant Neurologist His research emphasizes clinical and translational studies, particularly in Neurodegenerative Diseases , Biomarker Development , and Neuroimaging . Key contributions include validating Tau PET imaging and blood-based biomarkers for early Alzheimer's detection. Recent publications highlight applications in Alzheimer's disease subtyping , polygenic risk scores , and Lewy body disorder biomarkers (2025 publications in Nature Communications , The Lancet , and Alzheimer's Research and Therapy ). Current projects include active research on amyloid immunotherapies and tau pathology biomarkers. 2024 : Torsten Söderberg Professorship 2023 : De Leon Prize, ERC Advanced Grant, NIH/NIA R01 grant 2023 : Elsa and Alfred Eriksson Award Hansson leads the Clinical Memory Research platform and oversees multiple initiatives including the MultiPark Parkinson's research program and Proactive Ageing profile area at Lund University.







